Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers Drugs Comparisons API
Trackers› Clinical trials› Galway
Clinical trial register · Ireland

Clinical Trials in Galway, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Ireland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Alert me on this filter Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 602 matching records held by the registry are in this view. Synced 16 Oct 2026, 03:15 UTC
602
Studies in scope
all four open statuses
302
Recruiting now
open to new participants
164
Lead sponsors
across recruiting studies
37
Irish site locations
across all listed studies
Phase mix of the 302 recruiting studies
Phase 3 94 Not applicable 74 Observational 71 Phase 2 23 Phase 1/2 21 Other 19
Narrow the register Reset
Matches title, registry number, sponsor, intervention and condition.
Recruitment status
Phase
Lead sponsor
AbbVie 6 Cancer Trials Ireland 4 Regeneron Pharmaceuticals 4 National Cancer Institute (NCI) 4 Stichting Hemato-Oncologie voor Volwassenen Nederland 4
Site location
Dublin 484 Cork 169 Galway 125 Limerick 56 Waterford 52
All 37 locations
Target enrolment
to

Trials with a site in Galway

125 of 602 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Irish sites
Start
Not yet open
Tracheostomy Practice in Adult Intensive Care Units
NCT07769021 Tracheostomy Patients, Tracheostomy Decannulation, Intensive Care (ICU)
Royal College of Surgeons, Ireland
Observational
2,500
Dublin, Galway
2026-11-02
Recruiting
Takeda
Phase 3
324
Cork, Dublin, Galway
2026-09-10
Recruiting
Takeda
Phase 3
300
Cork, Dublin, Galway
2026-05-21
Recruiting
Eli Lilly and Company
Phase 2
600
Dublin, Galway
2026-05-13
Not yet open
A Single-Arm Interventional Trial of Pepper- Robot Delivered Cancer Education for Adults With Intellectual Disability
NCT07477938 Cancer Awareness and Prevention Education, Breast Cancer Awareness, Intellectual Disabilities (F70-F79)
National University of Ireland, Galway, Ireland
Not applicable
25
Galway
2026-05-01
Not yet open
National University of Ireland, Galway, Ireland
Not applicable
111
Galway
2026-04
Not yet open
Feeltect Limited
Not applicable
40
Galway
2026-01-15
Recruiting
University Hospital, Basel, Switzerland
Not applicable
1,060
Cork, Dublin, Galway
2026-01-01
Recruiting
Royal College of Surgeons, Ireland
Not applicable
30
Galway
2026-01-01
Recruiting
Eli Lilly and Company
Phase 3
800
Cork, Dublin, Galway
2025-12-22
Recruiting
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
NCT06793397 Major Depressive Disorder (MDD), Depression in Adults, Depression - Major Depressive Disorder, Depression Disorders
DrugCYB003
Cybin IRL Limited
Phase 3
330
Dublin, Galway
2025-12-10
Recruiting
Incyte Corporation
Phase 3
466
Dublin, Galway, Waterford
2025-12-09
Recruiting
University College Hospital Galway
Not applicable
130
Galway
2025-11-18
Recruiting
Cancer Trials Ireland
Not applicable
1,600
Dublin, Cork, Galway
2025-11-11
Recruiting
University of Galway
Not applicable
98
Galway
2025-10-20
Recruiting
Vertex Pharmaceuticals Incorporated
Phase 2/3
176
Cork, Dublin, Galway
2025-09-30
Recruiting
Boston Scientific Corporation
Not applicable
1,616
Cork, Dublin, Galway
2025-08-21
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
227
Cork, Dublin, Galway
2025-08-05
Recruiting
Boehringer Ingelheim
Phase 3
11,800
Ballinasloe, Dublin, Galway
2025-07-22
Recruiting
European Venous Registry
NCT06906250 Deep Venous Disease of the Lower Limbs
IRCCS San Raffaele
Observational
100
Galway
2025-07-05
Recruiting
Intervene, Inc.
Not applicable
20
Galway
2025-07-02
Recruiting
GlaxoSmithKline
Phase 3
981
Dublin, Cork, Drogheda, Galway, Mullingar
2025-06-20
Recruiting
BeOne Medicines
Phase 3
630
Dublin, Galway, Limerick
2025-06-11
Recruiting
Spyral InSight Study
NCT07013929 Hypertension, Vascular Diseases, Cardiovascular Diseases
Medtronic Vascular
Not applicable
19
Galway
2025-06-09
Recruiting
VitaFlow LIBERTY Europe
NCT06535659 Aortic Valve Stenosis
Shanghai MicroPort CardioFlow Medtech Co., Ltd.
Observational
222
Galway
2025-05-06
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
NCT06881784 NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer, NSCLC, NSCLC (Non-small Cell Lung Carcinoma)
DrugsCetuximab·Docetaxel
Revolution Medicines, Inc.
Phase 3
590
Cork, Dublin, Galway
2025-05-06
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
448
Cork, Dublin, Galway, Waterford
2025-05-05
Recruiting
SPYRAL GEMINI Pilot Study
NCT06907147 Hypertension, Vascular Diseases, Cardiovascular Diseases, Chronic Kidney Diseases
Medtronic Vascular
Not applicable
175
Galway
2025-05-01
Recruiting
Single vs. Multiple Fraction Trial of Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastases/Progression
NCT05784428 Oligometastatic Disease, Oligoprogression, Toxicity Due to Radiotherapy, Quality of Life
Robert Olson
Not applicable
598
Galway, Dublin, Cork, Waterford
2025-04-16
Recruiting
University Health Network, Toronto
Observational
3,000
Castlebar, Cork, Dublin, Galway, Waterford
2025-04-14
Recruiting
AstraZeneca
Phase 3
830
Cork, Dublin, Galway
2025-04-10
Recruiting
GlaxoSmithKline
Phase 3
520
Dublin, Galway, Waterford
2024-12-16
Active, closed
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
NCT06500455 Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Digestive System Carcinoma, Metastatic Lung Non-Small Cell Carcinoma
NRG Oncology
Phase 3
274
Dublin, Galway, Cork
2024-12-12
Recruiting
University of Dublin, Trinity College
Not applicable
248
Galway, Waterford
2024-11-13
Recruiting
Regeneron Pharmaceuticals
Phase 2
116
Galway, Cork, Dublin
2024-09-16
Active, closed
Alpine Immune Sciences Inc, A Subsidiary of Vertex
Phase 3
605
Cork, Dublin, Galway, Waterford
2024-08-30
Recruiting
University of Turin, Italy
Phase 3
420
Galway
2024-08-01
Active, closed
University of Galway
Phase 2
42
Galway
2024-07-09
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,530
Cork, Dublin, Galway
2024-06-24
Not yet open
University College Cork
Not applicable
840
Dublin, Galway, Wexford, Wicklow
2024-06
Recruiting
Daiichi Sankyo
Phase 1/2
680
Dublin, Cork, Galway
2024-04-10
Recruiting
The NEU-STIM Trial
NCT05942924 Infant, Premature, Diseases, Birth, Preterm
Leiden University Medical Center
Not applicable
3,280
Dublin, Galway
2024-03-11
Recruiting
PINTA - Prophylactic Incisional Negative Pressure Therapy for Major Amputations
NCT06025253 Wound Surgical, Wound Infection, Cosmesis
Royal College of Surgeons, Ireland
Not applicable
728
Dublin, Galway, Limerick, Waterford
2024-03-01
Recruiting
University of Turin, Italy
Observational
10,500
Galway
2024-01-15
Recruiting
University of Limerick
Observational
150
Dublin, Galway, Limerick, Tipperary
2024-01-11
Recruiting
Daiichi Sankyo
Phase 3
250
Cork, Dublin, Galway
2023-12-30
Recruiting
Janssen-Cilag Ltd.
Observational
900
Cork, Dublin, Galway
2023-12-18
Recruiting
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
NCT05934487 Heart Failure NYHA Class II, Heart Failure NYHA Class III, Heart Failure
Endotronix, Inc.
Not applicable
1,750
Galway
2023-11-29
Not yet open
University of Dublin, Trinity College
Phase 3
952
Cork, Dublin, Galway
2023-11
Active, closed
Cancer Trials Ireland
Phase 2
11
Galway, Dublin, Cork, Limerick
2023-10-26
Active, closed
Summit Therapeutics
Phase 3
1,600
Dublin, Galway
2023-10-26
Active, closed
AstraZeneca
Phase 3
5,511
Cork, Dublin, Galway, Waterford
2023-10-05
Recruiting
Biotest
Phase 3
590
Dublin, Galway
2023-09-09
Active, closed
PROPEL-2: Prophylactic Negative Pressure Wound Therapy in Laparotomy Wounds
NCT05977816 Wound Surgical, Wound Infection, Cosmesis
Royal College of Surgeons, Ireland
Not applicable
2,000
Castlebar, Dublin, Galway, Letterkenny, Limerick, Sligo, Waterford
2023-07-14
Active, closed
AbbVie
Phase 3
1,328
Dublin, Cork, Galway, Waterford
2023-06-21
Active, closed
Ultimaster Nagomi™ Sirolimus Eluting Coronary Stent System in Complex PCI Patients
NCT05705973 Cardiovascular Disease, Coronary Artery Occlusion, Ischemic Heart Disease
Terumo Europe N.V.
Observational
3,000
Cork, Dublin, Galway
2023-04-25
Active, closed
Karyopharm Therapeutics Inc
Phase 3
257
Dublin, Cork, Galway, Waterford
2023-04-18
Active, closed
AbbVie
Phase 3
520
Dublin, Cork, Galway, Sligo, Waterford
2023-03-15
Active, closed
Novo Nordisk A/S
Phase 3
7,101
Galway, Dublin
2023-03-01
Active, closed
COMPASS Pathways
Phase 3
572
Dublin, Galway
2023-02-14
Active, closed
Regeneron Pharmaceuticals
Phase 3
1,564
Galway, Cork, Dublin
2023-01-16
Active, closed
Incyte Corporation
Phase 3
82
Cork, Dublin, Galway
2022-12-23
Recruiting
AI-assisted CT for Risk Stratification in Coronary Artery Disease (ACTION)
NCT07577609 Coronary Artery Disease (CAD), Computed Tomography Angiography, Biomarkers, AI (Artificial Intelligence)
University of Galway
Observational
10,000
Galway
2022-12-21
Recruiting
European Myeloma Network (EMN) Sample Project
NCT06237803 Multiple Myeloma, Smoldering Multiple Myeloma, Plasma Cell Leukemia, Extramedullary Myeloma
European Myeloma Network B.V.
Observational
6,000
Galway
2022-12-21
Active, closed
The GORE® VIABAHN® FORTEGRA Venous Stent IVC Study
NCT05409976 Venous Thromboses, Venous Disease, Venous Leg Ulcer, Venous Stasis
W.L.Gore & Associates
Not applicable
136
Galway
2022-10-25
Active, closed
A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti-cancer Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer
NCT05587296 Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer, Hot Flashes
Bayer
Phase 3
474
Galway, Dublin, Cork, Waterford
2022-10-14
Active, closed
Eli Lilly and Company
Phase 3
8,000
Cork, Dublin, Galway, Sligo, Waterford
2022-10-04
Recruiting
Celgene
Phase 3
810
Galway, Cork, Dublin, Limerick
2022-09-20
Recruiting
Stereotactic Ablative Radiotherapy for OligoMetastatic Breast Cancer
NCT05377047 Breast Cancer Stage IV, Oligometastatic Disease
Vastra Gotaland Region
Phase 3
345
Cork, Dublin, Galway
2022-09-19
Recruiting
European Myeloma Network B.V.
Phase 3
1,594
Cork, Dublin, Galway, Limerick
2022-09-08
Active, closed
AbbVie
Observational
785
Abbotstown, Elm Park, Galway
2022-08-15
Recruiting
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Not applicable
538
Galway
2022-08-09
Active, closed
Mercator MedSystems, Inc.
Phase 2
60
Galway
2022-08-08
Active, closed
Regeneron Pharmaceuticals
Phase 3
1,546
Galway, Cork, Dublin
2022-07-14
Active, closed
Novartis Pharmaceuticals
Phase 3
610
Dublin, Galway
2022-07-08
Active, closed
Celgene
Phase 3
939
Cork, Dublin, Galway
2022-06-23
Active, closed
Evolut™ EXPAND TAVR II Pivotal Trial
NCT05149755 Moderate Aortic Valve Stenosis
Medtronic Cardiovascular
Not applicable
650
Galway
2022-04-27
Recruiting
AstraZeneca
Phase 2
630
Dublin, Galway
2022-04-14
Recruiting
University College, London
Phase 3
1,042
Dublin, Galway
2022-04-14
Recruiting
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
NCT05098132 Advanced Solid Tumor, Non Small Cell Lung Cancer, Untreated Advanced NSCLC, 1st Line NSCLC
DrugsPembrolizumab KEYTRUDA·Pemetrexed·Carboplatin
Synthekine
Phase 1/2
364
Dublin, Galway
2022-01-25
Active, closed
Cancer Trials Ireland
Phase 1
16
Cork, Dublin, Galway
2021-12-08
Recruiting
National University of Ireland, Galway, Ireland
Not applicable
2,540
Galway
2021-11-12
Recruiting
Mercator MedSystems, Inc.
Phase 2
80
Galway
2021-10-29
Active, closed
Beeline Medicines Corporation
Phase 2
248
Dublin, Galway, Manorhamilton
2021-10-11
Active, closed
Hoffmann-La Roche
Phase 3
4,170
Cork, Dublin, Galway, Limerick, Waterford
2021-08-27
Active, closed
Boston Scientific Corporation
Phase 4
544
Dublin, Galway
2021-08-02
Active, closed
Bristol-Myers Squibb
Phase 3
670
Manorhamilton, Dublin, Galway
2021-07-13
Active, closed
Incyte Corporation
Phase 3
654
Dublin, Galway
2021-04-15
Active, closed
German CLL Study Group
Phase 3
897
Cork, Dublin, Galway, Limerick, Waterford
2021-03-01
Recruiting
University Hospitals of Derby and Burton NHS Foundation Trust
Not applicable
1,900
Dublin, Galway
2021-02-26
Active, closed
Mirati Therapeutics Inc.
Phase 3
453
Tallaght, Dublin, Galway, Limerick
2021-02-23
Recruiting
Mirati Therapeutics Inc.
Phase 2/3
626
Cork, Dublin, Galway, Limerick, Waterford
2020-12-02
Active, closed
Multivessel TALENT
NCT04390672 Coronary Artery Disease, Myocardial Ischemia, Coronary Disease, Heart Diseases
National University of Ireland, Galway, Ireland
Not applicable
1,550
Galway
2020-09-22
Active, closed
University of Sydney
Phase 3
1,100
Rathgar, Cork, Dublin, Galway
2020-03-31
Active, closed
PROACTIVE-HF IDE Trial Heart Failure NYHA Class III
NCT04089059 Heart Failure NYHA Class III
Endotronix, Inc.
Not applicable
738
Galway
2020-01-10
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
777
Cork, Dublin, Galway, Limerick
2019-12-20
Active, closed
Foundry Innovation & Research 1, Limited (FIRE1)
Not applicable
50
Galway
2019-11-22
Active, closed
Inotrem
Phase 2
355
Dublin, Galway
2019-11-13
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,064
Dublin, Galway
2019-09-26
Active, closed
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase 2
90
Wilton, Galway, Rathgar, Dublin
2019-09-06
Active, closed
BeOne Medicines
Phase 3
510
Cork, Dublin, Galway, Limerick, Waterford
2019-08-20
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Observational
2,000
Dublin, Galway
2019-06-24
Active, closed
Regeneron Pharmaceuticals
Phase 3
415
Dublin, Cork, Galway
2019-06-04
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
968
Cork, Dublin, Galway
2019-03-01
Active, closed
The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension
NCT03614260 Hypertension, Vascular Diseases, Cardiovascular Diseases
ReCor Medical, Inc.
Not applicable
224
Galway
2018-12-14
Active, closed
AbbVie
Phase 3
1,336
Beaumont, Elm Park, Galway
2018-04-09
Active, closed
Breast Cancer Trials, Australia and New Zealand
Not applicable
1,167
Dublin, Galway
2017-08-21
Active, closed
Aarhus University Hospital Skejby
Not applicable
1,201
Galway
2017-07-05
Active, closed
AbbVie
Phase 3
950
Dublin, Elm Park, Cork, Galway
2017-01-31
Active, closed
Eisai Inc.
Phase 3
1,069
Cork, Dublin, Galway
2016-10-13
Active, closed
Tesaro, Inc.
Phase 3
733
Dublin, Dunmore RoadWaterford, Galway
2016-07-11
Recruiting
UMC Utrecht
Phase 3
20,000
Cork, Dublin, Galway, Waterford
2016-04-11
Active, closed
Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
NCT02506153 Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Cutaneous Melanoma, Metastatic Mucosal Melanoma
DrugsUrifron·Yervoy·Ipilimumab·Keytruda
National Cancer Institute (NCI)
Phase 3
1,301
Dublin, Galway, Waterford
2015-11-10
Active, closed
University College, London
Phase 3
11,000
Cork, Dublin, Galway, Limerick, Sligo, Waterford
2015-10
Active, closed
ETOP IBCSG Partners Foundation
Not applicable
518
Dublin, Galway, Limerick, Waterford
2014-12-04
Active, closed
University of Sydney
Phase 3
802
Cork, Galway, Dublin
2014-03
Active, closed
University of Sydney
Phase 3
1,125
Beaumont, Dublin, Galway, Tallaght, Waterford
2014-03
Active, closed
TAILORx Tissue Bank
NCT02050750 Breast Cancer
Cancer Trials Ireland
Observational
600
Cork, Donegal, Dublin, Galway, Limerick, Sligo, Waterford
2013-12
Active, closed
UNICANCER
Phase 3
1,173
Cork, Dublin, Galway
2013-11-13
Active, closed
NSABP Foundation Inc
Not applicable
1,636
Dublin, Galway
2013-08
Active, closed
AbbVie
Observational
8,250
Abbotstown, Dublin, Elm Park, Galway
2013-04-29
Recruiting
Product Surveillance Registry
NCT01524276 Cardiac Rhythm Disorders, Urological Disorders, Neurological Disorders, Cardiovascular Disorders
Medtronic
Observational
100,000
Galway
2012-01
Active, closed
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
NCT01272037 Breast Ductal Carcinoma In Situ, Invasive Breast Carcinoma, Multicentric Breast Carcinoma, Multifocal Breast Carcinoma
DrugsTamoxifen Citrate·Tamoxifen·Exemestane·Anastrozole
National Cancer Institute (NCI)
Phase 3
5,018
Cork, Dublin, Mount Merrion, Galway, Limerick, Sligo, Waterford, Letterkenny
2011-02-28
Active, closed
Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
NCT01169337 Light Chain Deposition Disease, Smoldering Multiple Myeloma
DrugLenalidomide
National Cancer Institute (NCI)
Phase 3
226
Dublin, Galway
2011-01-24
Active, closed
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
NCT00310180 Breast Adenocarcinoma, Hormone Receptor Positive, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7
DrugsTamoxifen Citrate·Tamoxifen·Exemestane·Anastrozole
National Cancer Institute (NCI)
Phase 3
10,273
Cork, Dublin, Mount Merrion, Galway, Limerick, Sligo, Waterford, Letterkenny
2006-04-07
Rows per page Showing 1–125 of 125
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Irish investigative site, filtered. Derived from ClinicalTrials.gov, U.S. National Library of Medicine. Retrieved 16 October 2026. https://priyalifescience.com/clinical-trials-ireland/city/galway

Query this register directly
GET /api/trials?country=ie&status=recruiting&phase=Phase+3&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Ireland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 602 studies in total at the last sync on 16 Oct 2026, 03:15 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 125 of those studies with a site in Galway.

How many clinical trials are recruiting in Galway?

57 of the 125 studies on this page are recruiting new participants as of the 16 Oct 2026, 03:15 UTC sync. A further 6 have not yet opened recruitment, 62 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Galway), 125 studies
PhaseStudiesRecruitingShare
Phase 3612248.8%
Not applicable321725.6%
Observational151012%
Phase 21048%
Phase 2/3322.4%
Phase 1/2221.6%
Phase 1100.8%
Phase 4100.8%

Most active sponsors

Lead sponsors with the most studies (Galway)
Lead sponsorStudiesRecruiting
AbbVie60
Cancer Trials Ireland41
National Cancer Institute (NCI)40
National University of Ireland, Galway, Ireland41
Regeneron Pharmaceuticals41
Royal College of Surgeons, Ireland42
Stichting Hemato-Oncologie voor Volwassenen Nederland42
AstraZeneca32
Eli Lilly and Company32
Incyte Corporation31
Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician. For trials across the wider EU, see the EU Clinical Trials Tracker.